Cargando…

Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials

AIM: Oxidative stress and endothelial dysfunction are two inter‐related conditions commonly seen in patients with cardiovascular risk factors. The enzyme, xanthine oxidase, is an important contributor to these phenomena but to a variable degree in different patient populations. This meta‐analysis wi...

Descripción completa

Detalles Bibliográficos
Autor principal: Alem, Manal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175067/
https://www.ncbi.nlm.nih.gov/pubmed/29673103
http://dx.doi.org/10.1111/1755-5922.12432
_version_ 1783361417334751232
author Alem, Manal M.
author_facet Alem, Manal M.
author_sort Alem, Manal M.
collection PubMed
description AIM: Oxidative stress and endothelial dysfunction are two inter‐related conditions commonly seen in patients with cardiovascular risk factors. The enzyme, xanthine oxidase, is an important contributor to these phenomena but to a variable degree in different patient populations. This meta‐analysis will summarize the effect of allopurinol, an established xanthine oxidase inhibitor, on endothelial function among patients with different comorbidities. METHODS: Medline Complete, PubMed, ProQuest, ClinicalKey, Wiley Online Library, and Cochrane Central Register of Controlled Trials were searched till July 29, 2017. Meta‐analysis was planned for randomized controlled trials (RCTs) that investigated allopurinol effects on endothelial function. A random effect model was used to calculate the standardized mean difference (with 95% confidence intervals: CI) as an estimate of effect size. Heterogeneity was quantified by four types of information: Q statistics, I (2) statistic, Tau‐squared (T (2)), and Tau (T). RESULTS: Thirty eligible studies were identified; 12 were included in the final analysis and subdivided among 3 patient’s groups: patients with chronic heart failure (CHF; 197 patients), patients with chronic kidney disease (CKD; 183 patients), and patients with type 2 diabetes mellitus (DM; 170 patients). Allopurinol was found to have a statistically significant benefit on endothelial function in patients with CHF and CKD but not in type 2 DM. The standardized mean differences and CI in the three patient’s groups were 0.776 (0.429, 1.122), 0.350 (0.009, 0.690), and 1.331 (−0.781, 3.444), respectively. CONCLUSION: Allopurinol has an antioxidant property that might partially reverse endothelial dysfunction in patients with certain comorbidities. The importance of this property and the magnitude of the beneficial effect are likely to be related to the relative contribution of xanthine oxidase into the oxidative stress associated with different underlying pathologies.
format Online
Article
Text
id pubmed-6175067
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61750672018-10-15 Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials Alem, Manal M. Cardiovasc Ther Original Research Articles AIM: Oxidative stress and endothelial dysfunction are two inter‐related conditions commonly seen in patients with cardiovascular risk factors. The enzyme, xanthine oxidase, is an important contributor to these phenomena but to a variable degree in different patient populations. This meta‐analysis will summarize the effect of allopurinol, an established xanthine oxidase inhibitor, on endothelial function among patients with different comorbidities. METHODS: Medline Complete, PubMed, ProQuest, ClinicalKey, Wiley Online Library, and Cochrane Central Register of Controlled Trials were searched till July 29, 2017. Meta‐analysis was planned for randomized controlled trials (RCTs) that investigated allopurinol effects on endothelial function. A random effect model was used to calculate the standardized mean difference (with 95% confidence intervals: CI) as an estimate of effect size. Heterogeneity was quantified by four types of information: Q statistics, I (2) statistic, Tau‐squared (T (2)), and Tau (T). RESULTS: Thirty eligible studies were identified; 12 were included in the final analysis and subdivided among 3 patient’s groups: patients with chronic heart failure (CHF; 197 patients), patients with chronic kidney disease (CKD; 183 patients), and patients with type 2 diabetes mellitus (DM; 170 patients). Allopurinol was found to have a statistically significant benefit on endothelial function in patients with CHF and CKD but not in type 2 DM. The standardized mean differences and CI in the three patient’s groups were 0.776 (0.429, 1.122), 0.350 (0.009, 0.690), and 1.331 (−0.781, 3.444), respectively. CONCLUSION: Allopurinol has an antioxidant property that might partially reverse endothelial dysfunction in patients with certain comorbidities. The importance of this property and the magnitude of the beneficial effect are likely to be related to the relative contribution of xanthine oxidase into the oxidative stress associated with different underlying pathologies. John Wiley and Sons Inc. 2018-05-24 2018-08 /pmc/articles/PMC6175067/ /pubmed/29673103 http://dx.doi.org/10.1111/1755-5922.12432 Text en © 2018 The Authors. Cardiovascular Therapeutics Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Alem, Manal M.
Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
title Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
title_full Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
title_fullStr Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
title_full_unstemmed Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
title_short Allopurinol and endothelial function: A systematic review with meta‐analysis of randomized controlled trials
title_sort allopurinol and endothelial function: a systematic review with meta‐analysis of randomized controlled trials
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175067/
https://www.ncbi.nlm.nih.gov/pubmed/29673103
http://dx.doi.org/10.1111/1755-5922.12432
work_keys_str_mv AT alemmanalm allopurinolandendothelialfunctionasystematicreviewwithmetaanalysisofrandomizedcontrolledtrials